Dr. Peter Lembke:
A life dedicated to Omega-3 research
Dr. Lembke has over 30 years of experience in the Omega-3 industry, where he has been responsible for the R&D, production, commercial and international expansion of highly concentrated Omega-3 fatty acids for the pharmaceutical and nutritional supplement industry. He has lectured and trained hundreds of international companies in the pharmaceutical industry and is an internationally renowned scientist with the deepest knowledge of these fatty acids and their health benefits.
“As a scientist dedicated to the study and development of Omega-3 fatty acids for over three decades, I cannot emphasize enough the profound impact these essential nutrients have on our health. Omega-3s, particularly DHA and EPA, play a crucial role in reducing inflammation, supporting heart health, and enhancing brain function. Integrating Omega-3s into our daily regimen is not just a dietary choice, but a vital step towards long-term well-being.”
Milestones within the Omega-3 industry
Pioneering the First Industrial SFC Process for Omega-3 Production
Dr. Peter Lembke graduated in Food Science and Chemistry at the University of Wuppertal, Germany and in his doctoral thesis developed the first industrial Supercritical Fluid Chromatography (SFC) process at the Institute of Applied Physical Sciences of the University of Saarbrücken, which was patented by the current world leader in the production of pharmaceutical Omega-3 fatty acids, the German KD-Pharma group in Bexbach (Germany).
Fatty Acid Extraction and Purification Plant (Tarragona, Spain)
In 1996 he moved to Spain as project manager for the manufacturing of the first extraction and purification plant of fatty acids for pharmaceutical and food use in Tarragona (KD IQA).
Foundation of Beps Biopharm
His professional career and a lifetime dedicated to the study and manufacture of fish oil, as well as a great desire to raise awareness of DHA and EPA fatty acids and their beneficial effects on our health, led him to create Beps Biopharm, a company specialized in the formulation of high quality and concentrated Omega-3 supplements in Spain, in 2001.
Creation of Puro Omega™ Brand
Its first brand Puro Omega™, is today one of the main Omega-3 brands recommended by the best trained health professionals in Omega-3 fatty acids in Spain.
Launch of DHANEO, third-generation premium Omega-3 supplements
DHANEO is a line of premium formulations with high concentrations of Omega-3. It consists of 5 products that offer a synergy of Omega-3 fatty acids with natural bioactives such as Coenzyme Q-10, Ginkgo, and Vitamins.
Aquisition of VitalRemedyMD
VitalRemedyMD's central goal is the formulation and production of top-quality, scientifically sound nutritional supplements. Additionally, it diligently and tirelessly follows medical literature to understand and respond to credible advances in nutritional medicine.
Creation of Omega-3 Academy
In desire to contribute to a better understanding of the science behind Omega-3 fatty acids in Spain and Latin American countries the educational platform www.omega3academy.com was launched, aiming hat health professionals of all specialties and providing a helpful tool to understand in more detail the benefits of Omega-3 polyunsaturated fatty acids.
Organisation of
Omega-3 Awareness Week 2022
International online symposium talking with some of the most well-known pioneers and specialists in Omega-3 about the importance of these long-chain polyunsaturated fatty acids for our health and wellbeing.
Creation of Omega-3 Awareness (O3A)
An educational platform to increase the awareness of the importance of Omega-3 fatty acids in our diet and their importance for human wellbeing. This site is mainly directed to health professionals of all specialities because they are key-people in communicating this awareness to their patients.
Breaking Ground: Dr. Peter Lembke's Debut Book on Omega-3 Fatty Acids and Optimal Health
Dr. Peter Lembke's inaugural book, "Omega-3 Fatty Acids: A Scientific Approach to Healthy Aging and Optimized Nutrition," published by Elsevier, is set to debut later this year.